Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 608 results.
User Information
Export Records
  1. 1.   Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
  2. Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang,Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo
  3. JCI Insight. 2025, Feb 24; 10(4):
  1. 2.   Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial
  2. Bonnett,Tyler; Potter, Gail E; Dodd, Lori E
  3. Clinical Trials (London, England). 2025, Feb 08; 17407745251313928.
  1. 3.   Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
  2. Guerra-de-Blas, Paola Del Carmen; Marines-Price, Rubria; Milman, Olga; Deal,Danae; Marchand,Jon; Linton,Jessica; Meger, Sue; Rule, John; Holland, Thomas L; Kitonsa, Jonathan; Delph, Yvette
  3. Journal of Clinical and Translational Science. 2024, Oct 15; 8(1): e157.
  1. 4.   Focusing HIV-1 Gag T-cell Responses to Highly Conserved Regions by DNA Vaccination in HVTN 119
  2. Kalams, Spyros A; Felber,Barbara; Mullins, James I; Scott, Hyman M; Allen, Mary A; De Rosa, Stephen C; Heptinstall, Jack; Tomaras, Georgia D; Hu, Jiani; deCamp, Allan C; Rosati,Margherita; Bear,Jenifer; Pensiero, Michael N; Eldridge, John; Egan, Michael A; Hannaman, Drew; McElrath, M Juliana; Pavlakis,George
  3. JCI Insight. 2024, Aug 01;
  1. 5.   Extracellular Matrix Scaffold-Assisted Tumor Vaccines Induce Tumor Regression And Long-Term Immune Memory
  2. Pal,Sanjay; Chaudhari, Rohan; Baurceanu,Iris; Hill,Brenna; Nagy,Bethany; Wolf,Matthew
  3. Advanced Materials (Deerfield Beach, Fla.). 2024, Feb 01; e2309843.
  1. 6.   Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
  2. Merker, Vanessa L; Thompson, Heather L; Wolters, Pamela L; Buono, Frank D; Hingtgen, Cynthia M; Rosser, Tena; Barton, Belinda; Barnett, Carolina; Smith, Taylor; Haberkamp, Diana; McManus, Miranda L; Baldwin,Andrea; Moss, Irene P; Röhl, Claas; Martin, Staci
  3. Clinical Trials (London, England). 2023, Dec 23; 17407745231205577.
  1. 7.   Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
  2. Wolters, Pamela L; Al Ghriwati,Nour; Baker, Melissa; Martin, Staci; Berg, Dale; Erickson, Gregg; Franklin, Barbara; Merker, Vanessa L; Oberlander, Beverly; Reeve, Stephanie; Rohl, Claas; Rosser, Tena; Vranceanu, Ana-Maria
  3. Clinical Trials (London, England). 2023, Nov 14;
  1. 8.   A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
  2. McDermott, David H; Velez, Daniel; Cho, Elena; Cowen, Edward W; DiGiovanna, John J; Pastrana, Diana V; Buck, Christopher B; Calvo, Katherine R; Gardner, Pamela J; Rosenzweig, Sergio D; Stratton, Pamela; Merideth, Melissa A; Kim, H Jeffrey; Brewer, Carmen; Katz, James D; Kuhns,Doug; Malech, Harry L; Follmann, Dean; Fay, Michael P; Murphy, Philip M
  3. The Journal of Clinical Investigation. 2023, Oct 2; 133(19): e164918.
  1. 9.   Structure of Complex III with Bound Antimalarial Agent CK-2-68 Provides Insights into Selective Inhibition of Plasmodium Cytochrome bc1 Complexes
  2. Esser, Lothar; Zhou, Fei; Zeher, Allison; Wu, Weimin; Huang, Rick; Yu, Chang-An; Lane, Kristin D; Wellems, Thomas E; Xia, Di
  3. The Journal of Biological Chemistry. 2023, Jul; 299(7): 104860.
  1. 10.   Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3-89 years from Uganda
  2. Nalwoga, Angela; Marshall,Vickie; Miley,Wendell; Labo,Nazzarena; Whitby,Denise; Newton, Robert; Rochford, Rosemary
  3. Infectious Agents and Cancer. 2023, Jun 14; 18(1): 38.
  1. 11.   Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case
  2. Ortega-Villa, Ana M; Hynes, Noreen A; Levine, Corri B; Yang, Katherine; Wiley, Zanthia; Jilg, Nikolaus; Wang,Jing; Whitaker, Jennifer A; Colombo, Christopher J; Nayak, Seema U; Kim, Hannah Jang; Iovine, Nicole M; Ince, Dilek; Cohen, Stuart H; Langer, Adam J; Wortham, Jonathan M; Atmar, Robert L; El Sahly, Hana M; Jain, Mamta K; Mehta, Aneesh K; Wolfe, Cameron R; Gomez, Carlos A; Beresnev, Tatiana; Mularski, Richard A; Paules, Catharine I; Kalil, Andre C; Branche, Angela R; Luetkemeyer, Annie; Zingman, Barry S; Voell, Jocelyn; Whitaker, Michael; Harkins, Michelle S; Davey, Richard T; Grossberg, Robert; George, Sarah L; Tapson, Victor; Short, William R; Ghazaryan, Varduhi; Benson, Constance A; Dodd, Lori E; Sweeney, Daniel A; Tomashek, Kay M
  3. Open Forum Infectious Diseases. 2023, Jun; 10(6): ofad290.
  1. 12.   Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
  2. Monge, Cecilia; Xie, Changqing; Myojin, Yuta; Coffman, Kelley; Hrones, Donna Mabry; Wang, Sophie; Hernandez, Jonathan M; Wood, Bradford J; Levy, Elliot B; Juburi, Israa; Hewitt, Stephen M; Kleiner, David E; Steinberg, Seth M; Figg, William D; Redd, Bernadette; Homan,Philip; Cam, Maggie; Ruf, Benjamin; Duffy, Austin G; Greten, Tim F
  3. Journal for Immunotherapy of Cancer. 2023, Feb; 11(2):
  1. 13.   Multitarget Potential of Phytochemicals from Traditional Medicinal Tree, Terminalia arjuna (Roxb. ex DC.) Wight & Arnot as Potential Medicaments for Cardiovascular Disease: An In-Silico Approach
  2. Kumar, Vikas; Sharma, Nitin; Orfali, Raha; Patel,Chiragkumar; Alnajjar, Radwan; Saini, Rakshandha; Sourirajan, Anuradha; Khosla, Prem Kumar; Dev, Kamal; Perveen, Shagufta
  3. Molecules (Basel, Switzerland). 2023, Jan 20; 28(3):
  1. 14.   A bioengineered in situ ovary (ISO) supports follicle engraftment and live-births post-chemotherapy
  2. Buckenmeyer,Michael; Sukhwani, Meena; Iftikhar, Aimon; Nolfi, Alexis L; Xian, Ziyu; Dadi, Srujan; Case, Zachary W; Steimer, Sarah R; D'Amore, Antonio; Orwig, Kyle E; Brown, Bryan N
  3. Journal of Tissue Engineering. 2023, Jan-Dec; 14: 20417314231197282.
  1. 15.   Improving Patient Advocacy in NCI Scientific Steering Committees and Task Forces
  2. Bangs, Rick; Lynn, Jean M; Obot,Evelyn; Osborne, Sherill; Norris, Kim
  3. Journal of the National Cancer Institute. 2022, May 12;
  1. 16.   Dysregulation of Hepatitis B Virus Nucleocapsid Assembly in vitro by RNA-binding Small Ligands
  2. Patel, Nikesh; Abulwerdi, Fardokht; Fatehi, Farzad; Manfield, Iain; Le Grice,Stuart; Schneekloth,Jay; Twarock, Reidun; Stockley, Peter G
  3. Journal of Molecular Biology. 2022, Mar 24; 167557.
  1. 17.   Complete Genome Sequence of Herpes Simplex Virus 2 Strain G
  2. Chang,Weizhong; Jiao, Xiaoli; Sui,Hongyan; Goswami, Suranjana; Sherman,Brad; Fromont,Caroline; Caravaca-Guasch,Juan Manuel; Tran,Bao; Imamichi,Tomozumi
  3. Viruses. 2022, Mar 05; 14(3):
  1. 18.   Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter
  2. Robey, Robert W.; Robinson, Andrea N.; Ali-Rahmani, Fatima; Huff, Lyn M.; Lusvarghi, Sabrina; Vahedi, Shahrooz; Hotz, Jordan M.; Warner,Andrew; Butcher,Donna; Matta,Jennifer; Edmondson,Elijah; Lee, Tobie D.; Roth, Jacob S.; Lee, Olivia W.; Shen, Min; Tanner, Kandice; Hall, Matthew D.; Ambudkar, Suresh; Gottesman, Michael M.
  3. SCIENTIFIC REPORTS. 2021, Dec 17; 11(1):
  1. 19.   RNF219 attenuates global mRNA decay through inhibition of CCR4-NOT complex-mediated deadenylation
  2. Poetz, Fabian; Corbo,Joshua; Levdansky,Yevgen; Spiegelhalter, Alexander; Lindner, Doris; Magg, Vera; Lebedeva, Svetlana; Schweiggert, Jorg; Schott, Johanna; Valkov,Eugene; Stoecklin, Georg
  3. Nature Communications. 2021, Dec 9; 12(1):
  1. 20.   The mechanism of Raf activation through dimerization
  2. Zhang,Mingzhen; Maloney,Ryan; Jang,Hyunbum; Nussinov,Ruth
  3. Chemical Science. 2021, Dec 08; 12(47): 15609-15619.
  1. 21.   Signaling in the crowded cell
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. Current Opinion in Structural Biology. 2021, Dec; 71: 43-50.
  1. 22.   Peptide hydrogels for affinity-controlled release of therapeutic cargo: Current and potential strategies
  2. Nambiar,Monessha; Schneider,Joel
  3. Journal of Peptide Science. 2021, Nov 7; e3377.
  1. 23.   Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
  2. Conlon, Kevin; Watson, Dionysios C; Waldmann, Thomas A; Valentin,Antonio; Bergamaschi,Cristina; Felber,Barbara; Peer, Cody J; Figg, William D; Potter, E Lake; Roederer, Mario; McNeel, Douglas G; Thompson, John A; Gupta, Sumati; Leidner, Rom; Wang-Gillam, Andrea; Parikh, Nehal S; Long, Debby; Kurtulus, Sema; Ho Lee, Lang; Chowdhury, Niladri Roy; Bender, Florent; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2021, Nov; 9(11):
  1. 24.   Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
  2. Murray, Daniel D.; Babiker, Abdel G.; Baker, Jason; Barkauskas, Christina E.; Brown, Samuel M.; Chang, Christina C.; Davey, Victoria J.; Gelijns, Annetine C.; Ginde, Adit A.; Grund, Birgit; Higgs, Elizabeth; Hudson, Fleur; Kan, Virginia L.; Lane, H. Clifford; Murray, Thomas A.; Paredes, Roger; Parmar, Mahesh K. B.; Pett, Sarah; Phillips, Andrew N.; Polizzotto, Mark N.; Reilly, Cavan; Sandkovsky, Uriel; Sharma, Shweta; Teitelbaum,Marc; Thompson, B. Taylor; Young, Barnaby E.; Neaton, James D.; Lundgren, Jens D.
  3. Clinical Trials. 2021, Oct 10;
  1. 25.   Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019
  2. Richard, Stephanie A; Epsi, Nusrat J; Pollett, Simon; Lindholm, David A; Malloy, Allison M W; Maves, Ryan; Utz, Gregory C; Lalani, Tahaniyat; Smith, Alfred G; Mody, Rupal M; Ganesan, Anuradha; Colombo, Rhonda E; Colombo, Christopher J; Chi, Sharon W; Huprikar, Nikhil; Larson, Derek T; Bazan, Samantha; Madar, Cristian; Lanteri, Charlotte; Rozman, Julia S; English, Caroline; Mende, Katrin; Tribble, David R; Agan, Brian K; Burgess, Timothy H; Powers,John
  3. Open Forum Infectious Diseases. 2021, Oct 8; 8(12): ofab517.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel